ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 271

Health Care Disparities for Infectious and Non-Infectious Uveitis in the US

Krati Chauhan1, Steven Scaife2 and James T. Rosenbaum3, 1Internal Medicine, Southern Illinois University School of Medicine, Springfield, IL, 2Center for clinical research, Southern Illinois University- School of Medicine, Springfield, IL, 3Ophthalmology, Oregon Health & Science University and Legacy Devers Eye Institute, Portland, OR

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Health disparities and uveitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Healthcare Disparities in Rheumatology Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Autoimmune disease like systemic lupus erythematous and rheumatoid arthritis are influenced by health care disparities due to race, income, sex and age. Uveitis is a frequent association with rheumatic diseases including ankylosing spondylitis, Behçet’s disease, and juvenile idiopathic arthritis. There is lack of national data regarding how health care disparities influence uveitis. The primary aim of our study is to compare the effect of race, income and insurance status in patients with infectious and non-infectious uveitis.

Methods:

We used the National Inpatient Sample (NIS) for the years 2002-2013. We used ICD-9 codes to identify infectious, noninfectious uveitis cases and ocular complications. We collected information on patient’s age, sex, race, income quartile of median household income for patients’ zip code and payer status. A multivariate logistic regression model was run to predict odds of developing infectious uveitis, non-infectious uveitis and ocular complications, adjusted for age, sex, race, income quartile of median household income for patient’s zip code and payer status. To assess the effect of income irrespective of race, we ran a logistic regression model, excluding African Americans. Statistical analysis was done using SAS version 9.4.

Results:

There were a total of 94,143,978 discharges, which included 15,296 total cases of uveitis, 4,538 cases of infectious uveitis and 10,758 cases of non-infectious uveitis. For a multivariate model odds of African Americans having infectious uveitis are five times: (OR = 5.37, 95% CI: 4.95-5.82) and having non-infectious uveitis are one and half times as compared to Caucasians: (OR = 1.43, 95% CI: 1.35-1.52). Odds of Medicare (OR = 2.21, 95% CI= 1.35-3.62) and Medicaid (OR = 1.7, 95% CI = 1.04-2.85) patients having complications from infectious uveitis are double and 1.7 times as compared to those with private insurance. Odds of Medicare (OR = 2.01, 95% CI= 1.46-2.71) and Medicaid (OR = 2.18, 95% CI = 1.51-3.16) patients having complications from non-infectious uveitis are double as compared to those with private insurance.

After excluding African Americans, patients with median household income for patient’s zip code of $ < 38,999 have 1.5 times odds of having infectious uveitis: (OR=1.54, 95% CI=1.38-1.71), as compared to those with median household income > $63,000. Medicare patients have 1.6 times the odds (OR = 1.6, 95% CI= 0.83-3.06) and Medicaid patients double (OR = 2.05, 95% CI = 1.05-4) the odds having ocular complications from infectious uveitis. And Medicare patients have 1.7 times the odds (OR = 1.7, 95% CI= 1.21-2.46) and Medicaid patients double (OR = 2.35, 95% CI = 1.54-3.58) the odds having ocular complications from non-infectious uveitis as compared to those with private insurance.

Conclusion:

African Americans have higher odds of developing infectious and non-infectious uveitis. Medicare and Medicaid patient have higher odds of developing complications from infectious and non-infectious uveitis. Uveitis should be added to the list of immune-mediated diseases which are affected by health care disparities. These disparities cannot be completely explained on the basis of racial or genetic factors.


Disclosure: K. Chauhan, Nowatski Eye Foundation, 2; S. Scaife, None; J. T. Rosenbaum, Alcon Research Institute, the Spondylitis Association of America (SAA), and Pfizer, 2,AbbVie, Gilead, Novartis, Regeneron, and UCB, 5.

To cite this abstract in AMA style:

Chauhan K, Scaife S, Rosenbaum JT. Health Care Disparities for Infectious and Non-Infectious Uveitis in the US [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/health-care-disparities-for-infectious-and-non-infectious-uveitis-in-the-us/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-care-disparities-for-infectious-and-non-infectious-uveitis-in-the-us/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology